Author Correction: High-Dimensional Detection of Imaging Response to Treatment in Multiple Sclerosis

npj Digital Medicine
doi 10.1038/s41746-019-0144-7
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Author Correction: Serum GFAP as a Biomarker for Disease Severity in Multiple Sclerosis

Scientific Reports
Multidisciplinary
2019English

Pharmacogenetic Biomarkers to Predict Treatment Response in Multiple Sclerosis: Current and Future Perspectives

Multiple Sclerosis International
Neurology
2017English

Author Correction: High-Speed Volumetric Imaging of Neuronal Activity in Freely Moving Rodents

Nature Methods
BiochemistryBiotechnologyCell BiologyMolecular Biology
2018English

Treatment of Multiple Sclerosis

Clinical Medicine and the Nervous System
1992English

Network Analysis of Transcriptional Regulation in Response to Intramuscular Interferon-Β-1a Multiple Sclerosis Treatment

Pharmacogenomics Journal
Molecular MedicineGeneticsPharmacology
2010English

Treatment Satisfaction in Multiple Sclerosis

International Journal of MS Care
NeurologySpecialized NursingAdvanced
2014English

Natalizumab Treatment in Multiple Sclerosis

Clinical Neurology
Neurology
2015English

Statistical Analysis of the TSAD Interactome in Multiple Sclerosis: Multiple Testing, High Dimensional Regression and Interactions

2019English

Correction To: Switching From Natalizumab to Fingolimod Treatment in Multiple Sclerosis: Real Life Data From the Austrian MS Treatment Registry

Journal of Neurology
Neurology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy